About A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)
During the past decade, A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)
According to Clinical.Site data, the most researched conditions in "A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)" are
"Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)" in a lesser frequency.
Clinical Trials Intervention Types at A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)
Most popular intervention types in "A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Fenebrutinib" (2 trials), "Ocrelizumab" (2 trials), "Placebo" (1 trials), "Placebo matched to fenebrutinib" (1 trials) and "Placebo matched to ocrelizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)
The vast majority of trials in "A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)" are
3 trials for "All" genders.
Clinical Trials Status at A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)
Currently, there are NaN active trials in "A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".